SIGNET RING CELL ADENOCARCINOMA
Clinical trials for SIGNET RING CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SIGNET RING CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for SIGNET RING CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Virus + drug combo tested for Tough-to-Treat skin cancers
Disease control OngoingThis study is testing a two-part treatment for patients with advanced skin cancers or rare lymphomas that have not responded to other therapies. First, a modified virus is injected directly into tumors to help the immune system recognize cancer. Then, an immunotherapy drug is giv…
Matched conditions: SIGNET RING CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Scientists try to turn 'Cold' tumors 'Hot' to fight spreading colon cancer
Disease control OngoingThis study is testing if a standard chemotherapy drug (oxaliplatin) can make advanced colon cancer more visible to the immune system. Researchers then add an immunotherapy drug (nivolumab) to see if this combination can stop the cancer from growing for a longer time. The trial is…
Matched conditions: SIGNET RING CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: University Hospital, Akershus • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC